Bloomberg
Glaxo CEO Walmsley on Tech Partnerships, Tesaro Acquisition, Pricing
Jan.13 -- Emma Walmsley, chief executive officer at GlaxoSmithKline Plc, discusses new tech partnerships, the acquisition of drugmaker Tesaro, and efforts to increase transparency in drug pricing. She speaks with Bloomberg's Taylor Riggs...
Bloomberg
Roche CEO Schwan Says New Medicines Driving 'Strong Growth'
Apr.17 -- Roche Holding AG Chief Executive Officer Severin Schwan talks about the company's financial results, outlook and strategy. Roche increased its forecast for this year as new drugs for multiple sclerosis and breast cancer helped...
AFP News Agency
VOICED : Costly medicines out of reach for millions in India
VOICED : Costly medicines out of reach for millions in India
Bloomberg
Good Hygiene Will Stop Ebola From Spreading: Singh
Oct. 24 -- Mundipharma APAC, Latin America, Mideast & Africa President Raman Singh discusses how to tackle Ebola and how one of his company's products can keep the virus from spreading with Bloomberg's Rishaad Salamat on ""On The Move.""...
Bloomberg
GlaxoSmithKline CEO Touts HIV Medicines, Pipeline
Oct. 26 -- Andrew Witty, chief executive officer at GlaxoSmithKline, discusses third-quarter results, the strength of the company’s HIV products, and what he calls a "class-leading" pipeline of new medicines. He speaks with Bloomberg's...
Bloomberg
Roche Pharma Unit Chief on Covid Tests, Alzheimer's Drug
Roche Pharmaceuticals CEO William Anderson discusses where the company is seeing growth in 2022, the distribution and manufacturing of Covid-19 tests, and the company's development of a drug for Alzheimer's disease. He speaks with...
Bloomberg
Bristol-Myers CEO on Delta Variant, Return of Office Workforce
Jul.28 -- Bristol-Myers Squibb CEO and Board Chair Giovanni Caforio discusses the surge of the delta variant, bringing their workforce back to the office, and the company’s drug portfolio. He speaks on "Bloomberg Markets: European Close."
Bloomberg
Roche CEO Is Confident on Growth Beyond 2019
Jul.25 -- Severin Schwan, chief executive officer at Roche, discusses the changes in the U.S. on biosimilar versions of Roche’s cancer drugs, the drugs that they are focusing on to continue growth, co-payment reform in the U.S., their...
Bloomberg
BeiGene CEO on Covid Collaborations, Regulation, China
Jun.02 -- John Oyler, co-founder, chief executive officer and chairman at BeiGene Ltd., a global pharmaceutical and biotechnology company, discusses the company’s partnerships on covid therapies, global regulations and the priorities in...
Bloomberg
AstraZeneca `Open' to M&A as Sales Forecast Raised on New Cancer Treatments: CEO
Jul.25 -- AstraZeneca Plc Chief Executive Officer Pascal Soriot speaks to Bloomberg after the U.K. drugmaker raised its annual sales forecast, helped by demand for its roster of new cancer drugs. He speaks on "Bloomberg Markets: European...
AFP News Agency
CLEAN : UNs aid chief in Ukraine says good relationship with rebels
CLEAN : UNs aid chief in Ukraine says good relationship with rebels
Bloomberg
Growth Entirely Driven by New Products, Says Roche CEO
Oct.17 -- Severin Schwan, chief executive officer at Roche, discusses 3Q results, new medicines, the stock price, competition from biosimilars, drug pricing in the U.S., his outlook for doing business in China and the impact of the trade...
Bloomberg
Novartis CEO: We Feel We Can Maintain Full Year Guidance
Apr.28 -- Vas Narasimhan, chief executive officer at Novartis AG, discusses why the company is keeping 2020 forecasts intact, the impact of coronavirus and his business outlook. He speaks on “Bloomberg Markets: European Open.”
Sky News
Humanitarian crisis in Democratic Republic of Congo reaching breaking point amid calls for President to step down
VOICED: Shows interior shots patients including mothers and children in overcrowded paediatrics wing of Bunia Hospital. Interior shots new born and very young babies in hospital looking extremely thin and malnourished. Interior shots new...
Bloomberg
Novartis Agrees to $6.8 Billion Medicines Co. Deal
Nov.25 -- Novartis has agreed to buy U.S. drug maker Medicines Co. for an equity value of $6.8 billion. Bloomberg’s Annmarie Hordern reports on “Bloomberg Daybreak: Europe.”
Bloomberg
GlaxoSmithKline's Redfern on Drug Pricing
Jan.11 -- GlaxoSmithKline Chief Strategy Officer David Redfern discusses drug pricing and mergers and acquisition activity under a Trump administration. He speaks on "What’d You Miss?"
Sky News
Health Secretary Matt Hancock gives daily press briefing
CLEAN: Interior shots of Health Secretary Matt Hancock MP giving the government's daily coronavirus press briefing on 28 April 2020 in London, United Kingdom
Bloomberg
Amgen CEO Bradway on Vaccine Rollout, New Products
Jan.07 -- Amgen Inc. Chairman and Chief Executive Officer Robert Bradway discusses the development and rollout of coronavirus therapies and vaccines, the impact of the Covid-19 pandemic on medical care, and new products. He speaks on...
Bloomberg
Bristol Myers CEO on Covid Drug Trials, Acquisitions, Texas Plant
Nov.19 -- Bristol Myers Squibb Chairman and Chief Executive Officer Giovanni Caforio discusses the clinical trials of the company's Covid-19 treatments, acquisition strategy, and progress on the inspection of its Texas facility by U.S....
Curated Video
Reax to plans for making over the counter drugs more widely available
1. Interior of Giannangeli Pharmacy in Rome
2. Close up of pharmacist putting medicine into bag, and taking money
3. Mid of pharmacist pulling out drawers of medicine
4. Mid of pharmacist searching for medicine
5. Various of medicines...
Curated Video
State Department reaction on the Somalian hostage crisis
1. Mid shot of Richard Boucher
2. SOUNDBITE: (English) Richard Boucher, US State Department Spokesperson
"Here is what we know, first of all nine o'clock local time in Mogadishu this morning, March 27th, militia loyal to a Mogadishu...
Bloomberg
Wuxi Biologics: Covid-19 Antibody Products Out By Year End
Aug.18 -- Chris Chen, chief executive officer at Wuxi Biologics Cayman Inc., discusses first-half earnings, the progress they’re making on Covid-19 treatments and the company’s expansion plans. He speaks exclusively on “Bloomberg...
Sky News
NICE New Antibiotics Guidelines Released Today
VOICED: The heath watchdog says doctors who hand out too many antibiotics should be disciplined. The National Institute for Health and Care Excellence or NICE has issue new guidelines today over the use of the drugs as it revealed as...